[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@frmrdrw2016](/creator/twitter/frmrdrw2016)
"$lexx Lexarias DehydraTECH technology has the potential to unlock accelerated revenue growth in the GLP1 industry. #pharma #Biotechnology"  
![@frmrdrw2016 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1861792290349658112.png) [@frmrdrw2016](/creator/x/frmrdrw2016) on [X](/post/tweet/1948063653095473387) 2025-07-23 16:52:22 UTC XX followers, XX engagements


"$LEXX entered in a material transfer agreement with a pharmaceutical company (PharmaCO) which was announced in September of 2024. Lexaria continues to collaborate with PharmaCO on evaluating DehydraTECH compositions. 👀 @grok what are the chances its Novo Nordisk 🔥 🚀"  
![@frmrdrw2016 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1861792290349658112.png) [@frmrdrw2016](/creator/x/frmrdrw2016) on [X](/post/tweet/1948015245785780587) 2025-07-23 13:40:01 UTC XX followers, XX engagements


"DehydraTECH isnt just theory its clinic-proven and industry-backed. W/commercial momentum building and pharma collaboration underway $LEXX is swinging X the fences in the GLP1 space. Imagine the upside if they license DehydraTECH as a goto platform for existing blockbusters"  
![@frmrdrw2016 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1861792290349658112.png) [@frmrdrw2016](/creator/x/frmrdrw2016) on [X](/post/tweet/1948065078638723220) 2025-07-23 16:58:02 UTC XX followers, XX engagements


"Lexaria hasnt confirmed the identityjust calling them PharmaCO. But Novo Nordisk is the leading prime suspect due to the overlap of technology drugs (semaglutide) and strategic fit. $LEXX stocks to watch"  
![@frmrdrw2016 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1861792290349658112.png) [@frmrdrw2016](/creator/x/frmrdrw2016) on [X](/post/tweet/1946022324861595833) 2025-07-18 01:40:52 UTC XX followers, XXX engagements